A Multicenter, Randomized, Double-blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell C

Clinical Trial Grant

Duke Scholars

Principal Investigator Meenal Kapoor Kheterpal Dermatology

Administered By

Dermatology

Awarded By

PellePharm

Start Date

January 8, 2019

End Date

November 9, 2021

Administered By

Dermatology

Awarded By

PellePharm

Start Date

January 8, 2019

End Date

November 9, 2021